Venmax Drugs and Pharmaceuticals Limited (BOM:531015)

BOM:531015 Revenue

Venmax Drugs and Pharmaceuticals had revenue of 13.19M INR in the quarter ending September 30, 2025, with 669.70% growth. This brings the company's revenue in the last twelve months to 30.61M, up 1,011.77% year-over-year. In the fiscal year ending March 31, 2025, Venmax Drugs and Pharmaceuticals had annual revenue of 8.07M.

• Revenue (ttm): 30.61M
• Revenue Growth: +1,011.77%
• P/S Ratio: 6.58
• Revenue / Employee: 15.30M
• Employees: 2
• Market Cap: 201.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	8.07M	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	1.68M	-3.04M	-64.45%